Literature DB >> 28298286

Echo Parameters for Differential Diagnosis in Cardiac Amyloidosis: A Head-to-Head Comparison of Deformation and Nondeformation Parameters.

Efstathios D Pagourelias1, Oana Mirea1, Jürgen Duchenne1, Johan Van Cleemput1, Michel Delforge1, Jan Bogaert1, Tatyana Kuznetsova1, Jens-Uwe Voigt2.   

Abstract

BACKGROUND: A plethora of echo parameters has been suggested for distinguishing cardiac amyloidosis (CA) from other causes of myocardial thickening with, however, scarce data on their head-to-head comparison. This study aimed at comparing the diagnostic accuracy of various deformation and conventional echo parameters in differentiating CA from other hypertrophic substrates, especially in the gray zone of mild hypertrophy (maximum wall thickness ≤16 mm) or normal ejection fraction (EF). METHODS AND
RESULTS: We included 100 subjects, of which 40 were patients with newly diagnosed, biopsy-proven CA (65.5±10.8 years, 65% male, 62.5% amyloidosis light chain [AL] type), 40 patients with hypertrophic cardiomyopathy matched for demographics and maximum wall thickness (60.1±14.8 years, 85% male), and 20 hypertensives with prominent myocardial remodeling. Quantifiable conventional morphological and functional parameters along with multidimensional strain and strain-derived ratios indices, previously suggested to diagnose CA, were analyzed. EF global longitudinal strain ratio showed the best performance to discriminate CA (area under the curve, 0.95; 95% confidence intervals, 0.89-0.98; P<0.00005). Traditional echo indices showed overall low sensitivities and high specificities (among them myocardial contraction fraction ratio had the highest area under the curve, 0.80; 95% confidence intervals, 0.7-0.87; P<0.0001). In the challenging subgroups (maximum wall thickness ≤16 mm and EF>55%), EF global longitudinal strain ratio remained the best predicting parameter of CA diagnosis (multiple logistic regression models P<0.00005 and P=0.0002, respectively) independent of the CA type.
CONCLUSIONS: Our study demonstrated that in patients with thickened hearts, EF global longitudinal strain ratio has the best accuracy in detecting CA, even among the most "challenging" patient subgroups as those with mild hypertrophy and normal EF.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  amyloid; area under curve; diagnosis; hypertrophic cardiomyopathy; myocardial contraction

Mesh:

Year:  2017        PMID: 28298286     DOI: 10.1161/CIRCIMAGING.116.005588

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  60 in total

Review 1.  Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.

Authors:  Frederick L Ruberg; Martha Grogan; Mazen Hanna; Jeffery W Kelly; Mathew S Maurer
Journal:  J Am Coll Cardiol       Date:  2019-06-11       Impact factor: 24.094

Review 2.  New developments in diagnosis, risk assessment and management in systemic amyloidosis.

Authors:  Iuliana Vaxman; Angela Dispenzieri; Eli Muchtar; Morie Gertz
Journal:  Blood Rev       Date:  2019-11-02       Impact factor: 8.250

Review 3.  The Role of Multimodality Imaging in Transcatheter Aortic Valve Replacement.

Authors:  Qi Liu; Rebecca T Hahn
Journal:  Curr Cardiol Rep       Date:  2019-07-19       Impact factor: 2.931

Review 4.  Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies.

Authors:  Ilia G Halatchev; Jingsheng Zheng; Jiafu Ou
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

5.  Imaging of cardiac amyloidosis: Will this become a unique application for dual-isotope imaging?

Authors:  Sarah Cuddy; Sharmila Dorbala; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2019-06-18       Impact factor: 5.952

6.  Quantitative single photon emission computed tomography derived standardized uptake values on 99mTc-PYP scan in patients with suspected ATTR cardiac amyloidosis.

Authors:  Juan Carlo Avalon; Jacob Fuqua; Seth Deskins; Tyler Miller; Justin Conte; Daniel Martin; Gary Marano; Naveena Yanamala; James Mills; Christopher Bianco; Brijesh Patel; Karthik Seetharam; Raymond Raylman; Partho P Sengupta; Yasmin S Hamirani
Journal:  J Nucl Cardiol       Date:  2022-06-02       Impact factor: 5.952

7.  Prevalence and prognostic impact of apical sparing contractility pattern in patients with aortic stenosis referred for transcatheter aortic valve implantation.

Authors:  Vera V Ferreira; Sílvia A Rosa; Tiago Pereira-da-Silva; Inês Rodrigues; António V Gonçalves; Tiago Mendonça; Alexandra Castelo; Luísa M Branco; Ana Galrinho; António Fiarresga; Ruben Ramos; Lino Patrício; Duarte Cacela; Rui C Ferreira
Journal:  Am J Cardiovasc Dis       Date:  2021-06-15

Review 8.  Fibrosis in hypertrophic cardiomyopathy: role of novel echo techniques and multi-modality imaging assessment.

Authors:  Efstathios D Pagourelias; Georgios M Alexandridis; Vassilios P Vassilikos
Journal:  Heart Fail Rev       Date:  2021-05-15       Impact factor: 4.214

Review 9.  Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis.

Authors:  Vasiliki Bistola; John Parissis; Emmanouil Foukarakis; Pipitsa N Valsamaki; Aris Anastasakis; Georgios Koutsis; Georgios Efthimiadis; Efstathios Kastritis
Journal:  Heart Fail Rev       Date:  2021-01-15       Impact factor: 4.214

10.  Transthyretin Amyloidosis (ATTR) - The Role of Multimodality in the Definitive Diagnosis.

Authors:  Tonnison de Oliveira Silva; Eduardo Sahade Darze; Luiz Eduardo Fonteles Ritt; André Luiz Cerqueira Almeida; Antônio Ximenes
Journal:  Arq Bras Cardiol       Date:  2020-05-18       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.